McKesson Corporation provides pharmaceuticals and medical supplies in the United States and internationally. It operates in three segments: U.S. Pharmaceutical and Specialty Solutions, European Pharmaceutical Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs, as well as other healthcare-related products; and offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices. It also provides specialty pharmaceutical solutions for pharmaceutical manufacturers; and medical-surgical supply distribution, logistics, and other services to healthcare providers. In addition, the company operates retail pharmacy chains in Europe and Canada, as well as supports independent pharmacy networks within North America and Europe; and supplies integrated pharmacy management systems, automated dispensing systems, and related services to retail, outpatient, central fill, specialty, and mail order pharmacies. Further, it provides software and analytics, network solutions, and technology-enabled services. The company serves retail national accounts, including national and regional chains, food and drug combinations, mail order pharmacies, and mass merchandisers; independent retail pharmacies; and institutional healthcare providers, such as hospitals, health systems, integrated delivery networks, and long-term care providers, as well as pharmaceutical manufacturers. McKesson Corporation was founded in 1833 and is headquartered in San Francisco, California.
Industry, Sector and Symbol
Industry Drugs, proprietaries, & sundries
Sub-IndustryHealth Care Distributors
SectorMedical
Phone415-983-8300
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$208.36 billion
Profitability
Miscellaneous
Employees78,000
OptionableOptionable
McKesson (NYSE:MCK) Frequently Asked Questions
What is McKesson's stock symbol?
McKesson trades on the New York Stock Exchange (NYSE) under the ticker symbol "MCK."
How often does McKesson pay dividends? What is the dividend yield for McKesson?
McKesson declared a quarterly dividend on Thursday, January 31st. Investors of record on Friday, March 1st will be paid a dividend of $0.39 per share on Monday, April 1st. This represents a $1.56 annualized dividend and a dividend yield of 1.15%. The ex-dividend date of this dividend is Thursday, February 28th. View McKesson's Dividend History.
How were McKesson's earnings last quarter?
McKesson Co. (NYSE:MCK) released its quarterly earnings data on Thursday, January, 31st. The company reported $3.40 earnings per share for the quarter, beating analysts' consensus estimates of $3.18 by $0.22. The firm earned $56.21 billion during the quarter, compared to analyst estimates of $55.27 billion. McKesson had a positive return on equity of 27.83% and a negative net margin of 0.15%. During the same period last year, the firm posted $3.41 earnings per share. View McKesson's Earnings History.
When is McKesson's next earnings date?
What guidance has McKesson issued on next quarter's earnings?
McKesson updated its FY19 earnings guidance on Thursday, January, 31st. The company provided earnings per share (EPS) guidance of $13.45-13.65 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $13.40.
What price target have analysts set for MCK?
13 analysts have issued 12-month price objectives for McKesson's stock. Their predictions range from $2.86 to $175.00. On average, they expect McKesson's stock price to reach $137.4418 in the next twelve months. This suggests a possible upside of 1.4% from the stock's current price. View Analyst Price Targets for McKesson.
What is the consensus analysts' recommendation for McKesson?
13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for McKesson in the last year. There are currently 8 hold ratings and 5 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for McKesson.
Has McKesson been receiving favorable news coverage?
Media stories about MCK stock have trended positive this week, according to InfoTrie Sentiment Analysis. InfoTrie identifies negative and positive media coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. McKesson earned a media sentiment score of 2.3 on InfoTrie's scale. They also assigned headlines about the company a news buzz of 6.0 out of 10, indicating that recent media coverage is somewhat likely to have an impact on the company's share price in the next several days.
Who are some of McKesson's key competitors?
Who are McKesson's key executives?
McKesson's management team includes the folowing people:
- Mr. John H. Hammergren, Chairman & CEO (Age 60)
- Britt J. Vitalone, CFO & Exec. VP (Age 50)
- Ms. Lori A. Schechter, Chief Compliance Officer, Exec. VP & Gen. Counsel (Age 57)
- Mr. Jorge L. Figueredo, Exec. VP & Chief HR Officer (Age 58)
- Mr. Bansi Nagji, Exec. VP and Chief Strategy & Bus. Devel. Officer (Age 54)
Who are McKesson's major shareholders?
McKesson's stock is owned by many different of institutional and retail investors. Top institutional investors include BlackRock Inc. (8.22%), Oregon Public Employees Retirement Fund (4.31%), Massachusetts Financial Services Co. MA (2.88%), Boston Partners (2.79%), Pzena Investment Management LLC (1.60%) and Bank of New York Mellon Corp (1.38%). Company insiders that own McKesson stock include Erin M Lampert, John H Hammergren, Lori A Schechter, M Christine Jacobs, Marie L/Ca Knowles and N Anthony Coles. View Institutional Ownership Trends for McKesson.
Which institutional investors are selling McKesson stock?
MCK stock was sold by a variety of institutional investors in the last quarter, including Boston Partners, Baupost Group LLC MA, Hsbc Holdings PLC, Millennium Management LLC, Bank of New York Mellon Corp, Unigestion Holding SA, Scharf Investments LLC and Great West Life Assurance Co. Can. Company insiders that have sold McKesson company stock in the last year include Erin M Lampert, Lori A Schechter and N Anthony Coles. View Insider Buying and Selling for McKesson.
Which institutional investors are buying McKesson stock?
MCK stock was purchased by a variety of institutional investors in the last quarter, including Oregon Public Employees Retirement Fund, CI Investments Inc., Massachusetts Financial Services Co. MA, River & Mercantile Asset Management LLP, BlackRock Inc., RWC Asset Management LLP, RWC Asset Management LLP and Canada Pension Plan Investment Board. View Insider Buying and Selling for McKesson.
How do I buy shares of McKesson?
Shares of MCK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is McKesson's stock price today?
One share of MCK stock can currently be purchased for approximately $135.56.
How big of a company is McKesson?
McKesson has a market capitalization of $26.00 billion and generates $208.36 billion in revenue each year. The company earns $67 million in net income (profit) each year or $12.62 on an earnings per share basis. McKesson employs 78,000 workers across the globe.
What is McKesson's official website?
How can I contact McKesson?
McKesson's mailing address is ONE POST ST MCKESSON PLAZA, SAN FRANCISCO CA, 94104. The company can be reached via phone at 415-983-8300 or via email at [email protected]
MarketBeat Community Rating for McKesson (NYSE MCK)
MarketBeat's community ratings are surveys of what our community members think about McKesson and other stocks. Vote "Outperform" if you believe MCK will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MCK will underperform the S&P 500 over the long term. You may vote once every thirty days.
